Prevalence of metabolic syndrome and its correlated factors among children and adolescents of Ahvaz aged 10 – 19

Journal of Diabetes & Metabolic Disorders

Marzieh Ghasemi¹  Kuroush Riahi¹  Majid Aminzadeh¹  Armaghan Moravej Aleali¹  Majid Karandish²  Seyed Mahmoud Latifi¹  Seyed Peyman Payami¹  Homeira Rashidi¹ 

[1] Health research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz 61357-15794, Iran;Nutrition and Metabolic research center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

关键词: Iran;    Cardiovascular risk factor;    Adolescents;    Children;    Prevalence;    Metabolic syndrome;   

Others  :  803505
DOI  :  10.1186/2251-6581-13-53

 received in 2013-02-06, accepted in 2014-03-08,  发布年份 2014

【 摘 要 】

Background

Population-based studies for prevalence of metabolic syndrome (M.S) in children and adolescents are relatively rare. The aim of this study was to assess the Prevalence of M.S and correlated factors among children and adolescents aged 10 to 19 years in Ahvaz.

Methods

In this descriptive-analytical population- based study, 2246 children and adolescents, 10–19 years old (1113 male and 1133 female) in Ahvaz, were evaluated. Anthropometry, biochemical measurement and blood pressure (BP) were assessed. Modified ATP III criteria 2005 were used for M.S. definition. Center for disease and Control preventions (CDC) percentile were applied to define cut off points of waist circumference and BP.

Results

Prevalence of M.S. was 9% (95% CI: 8-10%) with prevalence in male 11% (95% CI: 10-12%) and female 7% (95% CI 6-8%). Among individuals with M.S, triglyceride (TG) and decreased high density lipoprotein (HDL) cholesterol levels were the most common components (33.5% and 24.1%, respectively). Prevalence of M.S was higher in overweight persons comparing to participants with at risk and normal weight group (in male: 24.1%, 14.3% and 9.9% respectively P = 0.0001), (in female: 22.6%, 18.3% and 4.5% respectively P = 0.0001). Among the correlated factors of M.S age (P = 0.0006), sex and BMI (P = 0.0001) had significant differences between subjects with and without M.S. whereas there was no significant difference between two groups in ethnicity, history of breast fed, birth weight neonatal ICU admission, maternal history(GDM, gestational HTN, Parity) and family history of HTN, obesity and DM (P > 0.05).

Conclusion

This study shows high prevalence of M.S in Children and Adolescents in south west of Iran (Ahvaz) especially in overweight persons.

【 授权许可】

   
2014 Rashidi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
• [2]Rosenzweig JL, Ferrannini E, Grundy SM, Haffner SM, Heine RJ, Horton ES, Kawamori R, Endocrine Society: Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008, 10:3671-3689.
• [3]Zaliūnas R, Slapikas R, Luksiene D, Slapikiene B, Statkeviciene A, Milvidaite I, Gustiene O: Prevalence of metabolic syndrome components in patients with acute coronary syndromes. Medicina (Kaunas) 2008, 44(3):182-188.
• [4]Qadan LR, Ahmed AA, Safar HA, Al-Bader MA, Ali AA: Prevalence of metabolic syndrome in patients with clinically advanced peripheral vascular disease. Angiology 2008, 59(2):198-202.
• [5]Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH: Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 2003, 157:821-827.
• [6]Duncan GE, Li SM, Zhou XH: Prevalence and trends of a metabolic syndrome phenotype among U.S. Adolescents, 1999–2000. Diabetes Care 2004, 27(10):2438-2443.
• [7]Troiano RP, Flegal KM: Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics 1998, 101(3 Pt 2):497-504.
• [8]Mohammadpour Ahranjani B, Rashidi A, Karan Dish M, Eshraghian MR, Kalantari N: Prevalence of overweight and obesity in adolescent tehrani student S, 2000–2001: an epidemic health problem. Public Health Nutr 2004, 7:645-8.
• [9]Esmaillzadeh A, Mirmiram P, Azadbakht L, Etemadi A, Azizi F: High prevalence of the metabolic syndrome in Iranian Adolescents. Obesity 2006, 14(3):377-382.
• [10]Rodriguez Moran M, Salazar-Vazquez B, Violante R, Guerrero-Romero F: Metabolic syndrome among children and adolescents aged 10-18-years. Diabetes Care 2004, 27(10):2516-2517.
• [11]Harabbi I, Bouaouina M, Maatoug J, Gaha R, Ghannem H: Prevalence of the metabolic syndrome among urban schoolchildren in Sousse, Tunisia. Int J Cardiol 2009, 135(1):130-131.
• [12]Singh R, Bhansali A, Sialy R, Aggarwal A: Prevalence of metabolic syndrome in adolescents from a north Indian population. Diabet Med 2007, 24(2):195-199.
• [13]Li Y, Yang X, Zhai F, Kok FJ, Zhao W, Piao J, Zhang J, Cui Z, Ma G: Prevalence of the metabolic syndrome in Chinese adolescents. Br J Nutr 2008, 99(3):565-570.
• [14]Henneman P, Aulchenko YS, Frants RR, van Dijk KW, Oostra BA, van Duijn CM: Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study. J Med Genet 2008, 45(9):572-577.
• [15]Chiti H, Hosseinpanah F, Mehrabi Y, Azizi F: The prevalence of metabolic syndrome in adolescents with varing degree of body weight: Tehran Lipid And Glucose study(TLGS). Iran J Endocinol Metab 2010, 11(6):625-637.
• [16]Kelishadi R, Ardalan G, Gheiratmand R, Adeli K, Delavari A, Majdzadeh R: Paediatric metabolic syndrome and associated anthropometric indices: the CASPIAN Study. Acta Paediatr 2006, 95:1625-1634.
• [17]Salem Z, Vazirinejad R: Prevalence of metabolic syndrome components among children 7–11 years old in Rafsanjan 2008. Iran J Nutr Sci Food Ind 2010, 5(2):63-71.
• [18]Ghargerechi R, Razzaghy AM: Prevalence of Metabolic Syndrome in Obese Children and Adolescents Dolescents. Tbriz Med J 2010, 32(3):57-61.
• [19]Mirhosseini NZ, Yusoff NA, Shahar S, Parizadeh SM, Mobarhen MG, Shakery MT: Prevalence of the metabolic syndrome and its influencing factors among adolescent girls in Mashhad, Iran. Asia Pac J Clin Nutr 2009, 18:131-136.
• [20]De Ferranti SD, Osganian SK: Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus. Diab Vasc Dis Res 2007, 4(4):285-296.
• [21]Azizi F, Salehi P, Etemadi A, Zahedi-Asl S: Preavalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003, 61:29-37.
• [22]Etemadi A, Malekzadeh R: Definition and etiology of metabolic syndrome. Arch Iran Med 2008, 11:1-2.
• [23]Ghassemi H, Harrison G, Mohammad K: An accelerated nutrition transition in Iran. Public Health Nutr 2005, 5:149-155.
• [24]Rosenbloom A, Arsalanian S, Brink S, Conschafter K, Jones KL, Klingensmith G, Neufeld N, White N, Fagot-Campagna A, Gahagan S, Linder B: Type 2 diabetes in children and adolescents. Pediatrics 2000, 105(3 Pt 1):671-680.
• [25]Libman I, Arslanian SA: Type II diabetes mellitus: no longer just adults. Pediatr Ann 1999, 28:589-593.
• [26]Mancini M: Metabolic syndrome in children and adolescents: criteria for diagnosis. Diabetol Metab Syndr 2009, 19(1):20.